Status | Study |
Recruiting |
Study Name: STS/ACC TVT Registry Mitral Module Condition: Mitral Valve Regurgitation Date: 2014-09-02 Interventions: Device: Leaflet Clip |
Recruiting |
Study Name: Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS Condition: Sarcoma, Soft Tissue Date: 2013-11-21 Interventions: Drug: Pazopanib Other Name: Votrient |
Withdrawn |
Study Name: A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis Condition: Calcinosis Cutis Date: 2013-08-06 Interventions: Drug: Sodium thiosulfate A sma |
Active, not recruiting |
Study Name: A Phase II Study of Anlotinib in STS Patients Condition: Cancer Date: 2013-05-30 Interventions: Drug: Anlotinib |
Recruiting |
Study Name: STS/ACC Transcatheter Valve Therapy Registry (TVT Registry) Condition: Aortic Valve Stenosis Date: 2012-11-14 Interventions: Procedure: Transcatheter Aortic Valve Replacement Minimal invasive implantation of a biological prothesi |
Recruiting |
Study Name: Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma Condition: Soft Tissue Sarcoma (STS) Date: 2012-04-30 Interventions: Other: F18-FGD PET/CT |
Terminated |
Study Name: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) Condition: Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath T Date: 2011-08-15 Interventions: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib |
Completed |
Study Name: Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) Condition: Soft Tissue Sarcoma Date: 2011-05-02 Interventions: Procedure: External Beam Radiation Therapy (RT) |
Completed |
Study Name: Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide Condition: Soft Tissue Sarcoma Date: 2011-02-10 |
Terminated |
Study Name: Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS Condition: Sarcoma Date: 2010-04-13 Interventions: Drug: Doxorubicin A maximum of |